CHEILBIO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,080 KRW | -9.96% |
|
-.--% | -.--% |
| Sales 2022 | 15.35B 11.14M | Sales 2023 | 12.11B 8.79M | Capitalization | 56.18B 40.79M |
|---|---|---|---|---|---|
| Net income 2022 | -1.71B -1.24M | Net income 2023 | -1.45B -1.05M | EV / Sales 2022 | 0.75 x |
| Net cash position 2022 | 22.09B 16.04M | Net cash position 2023 | 19.83B 14.39M | EV / Sales 2023 | 3 x |
| P/E ratio 2022 |
-20
x | P/E ratio 2023 |
-38.5
x | Employees | 76 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.43% |
More Fundamentals
* Assessed data
More news
| 1 day | -9.96% |
1 year
1 555.00
2 605.00
3 years
1 131.004 530.00
5 years
1 131.005 825.00
10 years
1 131.005 825.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 84 | - | |
Dong-Kyun Im
AUD | Comptroller/Controller/Auditor | 36 | - |
Jae-Wan Jang
AUD | Comptroller/Controller/Auditor | 81 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 84 | - | |
Yoon-Jung Shim
BRD | Director/Board Member | 57 | - |
Jae-Yoon Kim
BRD | Director/Board Member | 49 | - |
Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Companyâs products are used for cattle, pigs, chickens, pets and other animals. It supplies its products mainly to the domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 40.93M | |
| -10.47% | 6.64B | |
| +16.00% | 3.41B | |
| +0.14% | 3.21B | |
| +2.53% | 1.46B | |
| -14.67% | 1.38B | |
| -2.44% | 1.25B | |
| -27.57% | 1.21B | |
| -12.86% | 1.13B | |
| -2.99% | 1.03B |
- Stock Market
- Equities
- A052670 Stock
